a study on Prostate Cancer
RATIONALE: Implant radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells.
PURPOSE: This phase II trial is studying the side effects and how well ultrasound-guided implant radiation therapy works in treating patients with locally recurrent prostate cancer previously treated with external-beam radiation therapy.
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy
OUTLINE: This is a prospective, multicenter study.
Patients undergo transperineal ultrasound-guided iodine I 125 or palladium Pd 103 brachytherapy.
Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually thereafter.
PROJECTED ACCRUAL: A total of 96 patients will be accrued for this study.
Prostate Cancer adenocarcinoma of the prostate recurrent prostate cancer stage I prostate cancer stage IIB prostate cancer stage IIA prostate cancer Iodine
For males ages 18–120
PRIOR CONCURRENT THERAPY:
© The Regents of the University of California